Agnete Fredriksen

Outlook Microsoft Office 365 WordPress.org Vimeo reCAPTCHA Google Analytics Mobile Friendly Nginx Google Tag Manager Remote

immunotherapy immunooncology neoantigens dna vaccine hpv16 neoepitopes oncology biotechnology research biopharmaceutical clinical-stage vaccine technology therapeutic cancer vaccine cancer treatment immune response vaccibody platform antigen targeting patient-centric solutions cancer neoantigen roche collaboration genentech phase 1b trial modular design hyper-targeting therapeutic areas autoimmunity drug development scientific strategy partnerships cancer vaccines hpv16-positive cancers long-lasting immunity immune system modulation innovative therapeutics game-changing medicine rapid immunization cancer immunotherapy biotech collaborations strategic partnerships personalized medicine antigen presenting cells research & development clinical trials pipeline expansion financial results investor relations corporate governance risk management technology platform drug discovery medical advancement cancer research analyzing clinical data biotechnology pharmaceutical innovations immunological therapies therapeutic modalities patient outcomes autoimmune diseases vaccibody technology therapeutic vaccines neoantigen immunotherapy modular immunotherapy antigen-presenting cells immune tolerance r&d collaborations patient-specific treatments transformative medicines market presence biopharma collaborations disease management unmet medical needs advanced technology clinical development patient demographics therapeutic focus modular platform immune modulation oncology market immune activation safety profile disease prevention therapeutic innovation hospital & health care health care health wellness & fitness